Bài kiểm tra có liên kết hướng dẫn · Trung bình Cấp độ
Nhận dạng mục tiêu AI trong bài kiểm tra khám phá thuốc
Kiểm tra các giả thuyết mục tiêu so với bằng chứng, loại bằng chứng, giải thích nguyên nhân, xác nhận thực nghiệm và bối cảnh sinh học.
Câu hỏi 1 của 8
What does a high target-disease score establish?
Xem trước mọi câu hỏi8 câu hỏi
Câu trả lời và giải thích xuất hiện khi bạn làm bài kiểm tra.
- What does a high target-disease score establish?
- Proof that a drug will treat the disease safely
- A causal mechanism in every tissue
- A clinical benefit in patients
- A prioritized hypothesis supported by the platform’s included evidence
- Why inspect the evidence behind a target association?
- Evidence provenance is irrelevant after ranking
- Different data types answer different questions and may be indirect
- All evidence types establish the same causal effect
- The score replaces the source data
- What would strengthen a candidate-target hypothesis experimentally?
- Perturb the target in a relevant model and reproduce the effect with another method
- Increase the number of computational features only
- Use the same assay repeatedly without controls
- Advance directly to patient treatment
- Why might a genetically associated target still be a poor drug target?
- A target score measures drug delivery
- A disease association guarantees tractability
- It may be inaccessible to a drug or cause harmful effects in other tissues
- Genetic evidence always means the target is safe
- Which source evidence is most clearly indirect?
- A controlled target perturbation in disease-relevant cells
- A rescue experiment after perturbation
- An orthogonal biochemical assay
- A literature-mined association without experimental confirmation in the relevant tissue
- Why can correlated evidence sources overstate confidence?
- They prove the target is causal
- They improve clinical outcomes automatically
- They may reflect overlapping data rather than independent confirmation
- They necessarily contradict each other
- What context should be documented before target experiments?
- Tissue, disease stage, target isoform, and expected direction of effect
- Only the database color scheme
- The preferred lab meeting day
- A platform score without its sources
- Can AI prioritization demonstrate clinical benefit?
- Yes, if a cell experiment changes a marker
- No; clinical benefit requires later study of a therapy and its outcomes
- Yes, if the model has a high score
- Yes, if several databases agree